je.st
news
Griffin Securities Reiterates $95.00 Price Target for Ligand Pharmaceuticals
2014-09-27 08:07:22| Biotech - Topix.net
Griffin Securities' price objective points to a potential upside of 98.25% from the company's current price. A number of other firms have also recently commented on LGND.
Tags: price
target
securities
griffin
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||